Higher vaginal pH is associated with Chlamydia trachomatis infection in women: A prospective case-controlled study

International Journal of STD and AIDS

Volumn 16, Issue 4, 2005, Pages 290-293

  Das, Satyajit ^a   Sabin, Caroline ^b   Allan, Sriskandab ^a  

^a Department of Genito Urinary Medicine and HIV Medicine   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Chlamydia trachomatis; Females; Vaginal pH

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ACIDITY; ADOLESCENT; ADULT; ALKALINITY; ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; PH MEASUREMENT; PRIORITY JOURNAL; RISK FACTOR; SEXUALLY TRANSMITTED DISEASE; VAGINA; VAGINA SECRETION; VAGINITIS;

EID: 18744366360     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462053654221     Document Type: Article

References (16)

1. Hanna NF, Taylor-Robinson D, Karamanoli-Kalodiki M, et al. The relation between vaginal pH and the microbiological status in vaginitis. Br J Obstet Gynaecol 1985;92: 1267-71
2. Mahmoud EA, Svensson LO, Olsson SE, et al. Antichlamydial activity of vaginal secretion. Am J Obstet Gynecol 1995;172:1268-72
3. Boskey ER, Telsch KM, Whaley KJ, et al. Acid production by vaginal flora in vitro is consistent with the rate and extent of vaginal acidification. Infect Immun 1999;67:5170-5
4. Yasin B, Pang M, Wager A, et al. Chlamydia trachomatis infection in environments mimicking normal and abnormal vaginal pH. Proceedings of the fourth meeting of the European Society for Chlamydia Research, Helsinki, Finland, August 2000;296.
5. Cohen MS, Weber RD, Mårdh P-A. Genitourinary mucosal defences In: Holmes KK, Mårdh P-A, Sparling FR et al., eds. Sexually Transmitted Diseases. New York: McGraw Hill, 1990; 117-27
6. Charbonnel B, Kremer M, Gerozissis K, et al. Human cervical mucus contains large amounts of prostaglandins. Fertil Steril 1982;38:109-11
7. Mahmoud EA, Hamad EE, Olsson S-E, et al. Antichlamydial activity of cervical secretion in different phases of menstrual cycle and influence of hormonal contraceptives. Contraception 1994;49:265-74
8. Schramm N, Bagnell CR, Wyrick PB. Vesicles containing Chlamydia trachomatis serover L2 remain above pH 6 within HEC-1B cells. Infect Immun 1996;64:1208-14
9. Matikainen MT. Effect of pH on reactivity of monoclonal antibodies to Chlamydia. J Immunol Methods 1984;75: 211-16
10. Peters SE, Beck-Segue CM, Farshy CE, et al. Behaviours associated with Neisseria gonorrhoeae and Chlamydia trachomatis: cervical infection among young women attending adolescent clinics. Clin Pediatr 2000;39:173-7
11. Ripa KT, Svenssn L, Mårdh P-A, et al. Chlamydia trachomatis cervicitis in gynaecologic outpatients. Obstet Gynecol 1978; 52:698-702
12. Svensson L, Westrom L, Mårdh P-A. Chlamydia trachomatis in women attending a gynaecological outpatients clinic with lower genital tract infection. Br J Vener Dis 1981;57: 259-62
13. Chen KCS, Forsyth PS, Buchanan TM, et al. Amine content of vaginal fluid from untreated and treated patients with non-specific vaginitis. J Clin Invest 1979;63:828-35
14. Donders GG, Bosnians E, Dekeersmaecker A, et al. Pathogenesis of abnormal vaginal bacterial flora. Am J Obstet Gynecol 2000;182:872-8
15. Wiesenfield HC, Hillier SL, Krohn MA, et al. Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection. Clin Infect Dis 2003;36: 663-8
16. Steinhandler L, Peipert JF, Heber W, et al. Combination of bacterial vaginosis and leukorrhoea as a predictor of cervical chlamydial or gonococcal infection. Obstet Gynecol 2002;99:603-7